Smartphone-assisted psychoeducation in adult attention-deficit/hyperactivity disorder: A randomized controlled trial.
Adult ADHD
Digital health
Group psychotherapy
Medical technology
Mobile app
Psychoeducation
RCT
Smartphone
mHealth applications
Journal
Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
13
07
2022
revised:
15
08
2022
accepted:
18
08
2022
pubmed:
31
8
2022
medline:
18
11
2022
entrez:
30
8
2022
Statut:
ppublish
Résumé
Psychoeducation is generally recommended in the treatment of adult Attention-Deficit/Hyperactivity Disorder (ADHD), but only few studies have systematically assessed the effects of structured clinical psychoeducation. Moreover, although a considerable number of psychoeducational mobile applications exist, none have provided scientific evidence for their effectiveness or safety. Therefore, the present randomized controlled trial investigated a newly developed, free-to-use psychoeducation app for adults with ADHD as a support to a clinical psychoeducation group. 236 adults with ADHD were contacted for study participation, of whom 60 were finally randomized to a psychoeducation group supported either by our developed smartphone app (n = 30) or by traditional pen-and-paper brochures (n = 30). Psychoeducation treatments were conducted in groups of 10, with 8 weekly one-hour sessions between March 2019 and November 2020. Observer-rated ADHD symptom severity (IDA-R interview) was examined as the primary outcome parameter before and after treatment. Across both interventions, ADHD core symptoms were significantly reduced. Notably, the smartphone-assisted psychoeducation was significantly more effective in improving inattention and impulsivity and led to higher homework compliance than the brochure-assisted psychoeducation. No adverse events were reported.
Identifiants
pubmed: 36041353
pii: S0165-1781(22)00396-1
doi: 10.1016/j.psychres.2022.114802
pii:
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
114802Informations de copyright
Copyright © 2022. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest BS and NB received funding by BONFOR and the German Federal Ministry of Education and Research. Over the past three years, AP received funding by the German Federal Ministry of Education and Research, Horizon2020, and DFG; she reports serving on advisory boards for Takeda, Medice, and Boehringer; and delivering lectures sponsored by Medice, Takeda; and being the author of books and articles on psychotherapy. All other authors declare no conflict of interests.